NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries
Clinical trial NCT04081103 · TERMINATED
Trial details
- NCT number
- NCT04081103
- Sponsor
- Glaukos Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2022-02-07
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.